Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | JMJD6 | Q6NYC1 | 3/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | IDE | P14735 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4301925 | 0.91 | JMJD6 (0.43) | L3MBTL1MAPTALDH1A1CYP1A2JMJD6 | |
| SCHEMBL743661 | 0.84 | L3MBTL1 (0.58) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| Hydrochloric Acid SCHEMBL4217802 | 0.83 | L3MBTL1 (0.56) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| SCHEMBL3327719 | 0.81 | CYP1A2 (0.61) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| SCHEMBL25275643 | 0.80 | PIK3C3 (0.44) | GABRA2GABRB2 | |
| SCHEMBL1200252 | 0.80 | GABRA2 (0.55) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| SCHEMBL31127029 | 0.76 | CYP1A2 (0.51) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| SCHEMBL787591 | 0.76 | CYP1A2 (0.51) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| SCHEMBL2823510 | 0.76 | CYP1A2 (0.51) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 | |
| Toluene SCHEMBL5966394 | 0.76 | MAPT (0.49) | L3MBTL1MAPTALDH1A1CYP1A2GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090044345-A1 | Use of Metal Complex Compounds as Oxidation Catalysts | CIBA CORP. | 2009-02-19 | — | — | US | disclosed |
| US-20090044345-A1 | Use of Metal Complex Compounds as Oxidation Catalysts | CIBA CORP. | 2009-02-19 | — | — | US | disclosed |
| US-20090044345-A1 | Use of Metal Complex Compounds as Oxidation Catalysts | CIBA CORP. | 2009-02-19 | — | — | US | disclosed |
| WO-2007090461-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA HOLDING INC. (CH) | 2007-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090044345-A1 | Use of Metal Complex Compounds as Oxidation Catalysts | MT-CO2, MT-CO1, SOD1 | L3MBTL1 4714/4885MAPT 1558/4885ALDH1A1 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.